Onconetix, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other
Onconetix, Inc. (ONCO) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other of $89.60 thousand as of 2023-06-30, per its 10-Q filed 2023-10-20.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Tax Deferred Expense › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther · last filed 2023-10-20
- 2023-06-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other $89.60K.
- 2023-03-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other $26.20K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other $177.60K.
- 2022-09-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other $1.31M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other |
|---|---|
| 2023-06-30 | $89.60K 10-Q · filed 2023-10-20 |
| 2023-03-31 | $26.20K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $177.60K 10-Q · filed 2023-10-20 |
| 2022-09-30 | $1.31M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $520.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |